Antibiotics (Sep 2020)

Indoline-6-Sulfonamide Inhibitors of the Bacterial Enzyme DapE

  • Cory T. Reidl,
  • Tahirah K. Heath,
  • Iman Darwish,
  • Rachel M. Torrez,
  • Maxwell Moore,
  • Elliot Gild,
  • Boguslaw P. Nocek,
  • Anna Starus,
  • Richard C. Holz,
  • Daniel P. Becker

DOI
https://doi.org/10.3390/antibiotics9090595
Journal volume & issue
Vol. 9, no. 9
p. 595

Abstract

Read online

Inhibitors of the bacterial enzyme dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE; EC 3.5.1.18) hold promise as antibiotics with a new mechanism of action. Herein we describe the discovery of a new series of indoline sulfonamide DapE inhibitors from a high-throughput screen and the synthesis of a series of analogs. Inhibitory potency was measured by a ninhydrin-based DapE assay recently developed by our group. Molecular docking experiments suggest active site binding with the sulfonamide acting as a zinc-binding group (ZBG).

Keywords